Uncovering Symptom Progression History from Disease Registry Data with Application to Young Cystic Fibrosis Patients

被引:3
|
作者
Yan, Jun [1 ,2 ]
Cheng, Yu [3 ,4 ]
Fine, Jason P. [5 ]
Lai, HuiChuan J. [6 ,7 ]
机构
[1] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
[2] Univ Connecticut, Publ Hlth Res Inst, Storrs, CT 06269 USA
[3] Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA
[5] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[6] Univ Wisconsin, Dept Nutr Sci, Dept Biostat & Med Informat, Madison, WI 53706 USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA
基金
美国国家科学基金会;
关键词
Generalized linear model; Lung infection; Newborn screening and diagnosis; Prevalence: Pseudomonas aeruginosa; Varying coefficient; PSEUDOMONAS-AERUGINOSA INFECTION; REGRESSION; SURVIVAL; PREVALENCE; COLONIZATION; RECURRENT;
D O I
10.1111/j.1541-0420.2009.01288.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The growing availability of various disease registry data has brought precious opportunities to epidemiologists to understand the natural history of the registered diseases. It also presents challenges to the traditional data analysis techniques because of complicated censoring/truncation schemes and temporal dynamics of covariate influences. In a case study of the Cystic Fibrosis Foundation Patient Registry data, we propose analyses of progressive symptoms using temporal process regressions, as an alternative to the commonly employed proportional hazards models. Two endpoints are considered, the prevalence of ever positive and currently positive for Pseudomonas aeruginosa. (PA) infection in the lungs, which capture different aspect of the disease process. The analysis of ever PA positive via, a time-varying coefficient model demonstrates the lack of fit, as well as the potential loss of information, in the standard proportional hazards analysis. The analysis of currently PA positive yields results that are clinically meaningful and have not previously been reported in the cystic fibrosis literature. Our analyses demonstrate that prenatal/neonatal screening results in lower prevalence of PA infection compared to traditional diagnosis via, signs and symptoms, but this benefit attenuates with age. Calendar years of diagnosis also affect the risk of PA infection; patients diagnosed in more recent cohort show higher prevalence of ever PA positive but lower prevalence of currently PA positive.
引用
收藏
页码:594 / 602
页数:9
相关论文
共 50 条
  • [41] Progression of early structural lung disease in young children with cystic fibrosis assessed using CT
    Mott, Lauren S.
    Park, Judy
    Murray, Conor P.
    Gangell, Catherine L.
    de Klerk, Nicholas H.
    Robinson, Philip J.
    Robertson, Colin F.
    Ranganathan, Sarath C.
    Sly, Peter D.
    Stick, Stephen M.
    THORAX, 2012, 67 (06) : 509 - 516
  • [42] Patterns of Health Insurance Coverage and Lung Disease Progression in Adolescents and Young Adults with Cystic Fibrosis
    Tumin, Dmitry
    Crowley, Erin M.
    Li, Susan S.
    Wooten, William
    Ren, Clement L.
    Hayes, Don, Jr.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (02) : 290 - 299
  • [43] Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease Data From the Pulmonary Fibrosis Foundation Patient Registry
    Lee, Janet
    White, Emily
    Freiheit, Elizabeth
    Scholand, Mary Beth
    Strek, Mary E.
    Podolanczuk, Anna J.
    Patel, Nina M.
    CHEST, 2022, 162 (03) : 603 - 613
  • [44] Is the Cystic Fibrosis Neutrophil a Contributor to Disease Progression? A Proteomic Analysis of Neutrophil Membrane Proteins from Cystic Fibrosis and Control Subjects
    Hayes, E.
    Reeves, E. P.
    Bergsson, G.
    Bergin, D. A.
    O'Neill, S. J.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [45] Characterization of Progression in Patients with interstitial Lung Disease - Data from the EXCITING- ILD Registry
    Buschulte, K.
    Kabitz, H.
    Hagmeyer, L.
    Hammerl, P.
    Esselmann, A.
    Wiederhold, C.
    Skowasch, D.
    Stolpe, C.
    Joest, M.
    Veitshans, S.
    Hoeffgen, M.
    Maqhuzu, P.
    Schwarzkopf, L.
    Hellmann, A.
    Pfeifer, M.
    Behr, J.
    Guenther, A.
    Polke, M.
    Markart, P.
    Kreuter, M.
    PNEUMOLOGIE, 2024, 78 : S80 - S80
  • [46] Cardiovascular Events in Patients With Fabry Disease Natural History Data From the Fabry Registry
    Patel, Manesh R.
    Cecchi, Franco
    Cizmarik, Marta
    Kantola, Ilkka
    Linhart, Ales
    Nicholls, Kathy
    Strotmann, Joerg
    Tallaj, Jose
    Thi Chien Tran
    West, Michael L.
    Beitner-Johnson, Dana
    Abiose, Ademola
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (09) : 1093 - 1099
  • [47] CARDIOVASCULAR EVENTS IN PATIENTS WITH FABRY DISEASE: NATURAL HISTORY DATA FROM THE FABRY REGISTRY
    Patel, Manesh R.
    Cecchi, Franco
    Cizmarik, Marta
    Kantola, Ilkka
    Linhart, Ales
    Nicholls, Kathy
    Strotmann, Jorg
    Tallaj, Jose
    Tran, Thi Chien
    West, Michael L.
    Abiose, Ademola
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [48] Long term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis
    Milla, CE
    THORAX, 1998, 53 (12) : 1014 - 1017
  • [49] The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis
    Trojan, T.
    Alcazar, Miguel A. Alejandre
    Fink, G.
    Thomassen, J. C.
    Maessenhausen, M., V
    Rietschel, E.
    Schneider, P. M.
    Van Koningsbruggen-Rietschel, S.
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [50] The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis
    T. Trojan
    Miguel A. Alejandre Alcazar
    G. Fink
    J. C. Thomassen
    M. V. Maessenhausen
    E. Rietschel
    P. M. Schneider
    S. van Koningsbruggen-Rietschel
    BMC Pulmonary Medicine, 22